Prolonged survival in follicular non hodgkins lymphoma is predicted by achievement of complete remission with initial treatment: Results of a long term study with multivariate analysis of prognostic factors

Leukemia and Lymphoma

Volumn 24, Issue 1-2, 1996, Pages 131-140

  Davidge Pitts, M ^a   Dansey, R ^a   Bezwoda, W R ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Low grade non Hodgkin's lymphoma; Prognostic factors; Survival

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISOLONE; PROCARBAZINE; VINCRISTINE;

AGE; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; FEMALE; FOLLICULAR LYMPHOMA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NONHODGKIN LYMPHOMA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE;

AGE DISTRIBUTION; ANTINEOPLASTIC AGENTS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHOMA, FOLLICULAR; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 0030453867     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199609045721     Document Type: Article

References (46)

1. Armitage, J. O. (1993). Treatment of non-Hodgkin's lymphoma, New England Journal of Medicine, 328, 1023-1030.
2. Straus, D. J., Filippa, D. A., Lieberman, P. H., Koziner, B., Thaler, H T. and Clarkson, B. D. (1983). The non-Hodgkin's Lymphomas: I. A retrospective clinical and pathologic analysis of 499 cases diagnosed between 1958-1969, Cancer, 51, 101-109.
3. The Non-Hodgkin's lymphoma pathologic classification project: National Cancer Institute sponsored study of classifications of Non-Hodgkin's lymphomas: Summary and description of a working formulation for clinical usage. (1982). Cancer, 49, 2112-2135.
4. Medeiros, J., Van Krieken, J. H., Jaffe, E. S. and Raffeld, M. (1990). Association of bcl-1 rearrangements with lymphocytic lymphoma of intermediate differentiation, Blood, 76, 2086-2090.
5. Hockenberry, D , Nunez, G., Millman, C , Schreiber, R. D. and Korsmeyer, S. J. (1990). bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death, Nature, 348, 334-.
6. Lo Coco, F., Gaidano, G., Louie, D. C., Offik, K., Chaganti, R. S. K and Dalla-Favera, R. (1993). p53 mutations are associated with histologic transformation of follicular lymphoma, Blood, 82, 2289-2295.
7. Baron, B. W., Nucifora, G., McCabe, N., Espinosa, R. 3rd, Le Beau, M. M. and McKeithan, T. W. (1993). Identification of the gene associated with the recurring chromosomal translocations t(3.14) (q27;q32) and t(3;22)(q27;q11) in B-cell lymphomas, Proceedings of National Academy of Sciences of United States of America, 90, 5262-5266.
8. Jaffe, E. S., Raffeld, M., Medeiros, L. J and Stetler-Stevenson, M. (1992). An overview of the classification of non-Hodgkin's lymhomas: an integration of morphological and phenotypical concepts, Cancer Research (Suppl), 52, 5447-.
9. Croce, C M. (1993). Molecular biology of lymphomas, Seminars in Oncology, 20, 31-47.
10. Asenberg, A C. (1993). Utility of gene rearrangements in lymphoid malignancies, Annual Review of Medicine, 44, 75-84
11. Carbone, A., Pinto, A., Gloghini, A., Volpe, R. and Zagonel, V. (1992). B-zone small lymphocytic lymphoma: a morphologic, immunophenotypic, and clinical study with comparison to 'well-differentiated' lymhocytic disorder, Human Pathology, 23, 438-448.
12. Rosenberg, S. A. (1985). The low grade non-Hodgkin's lymphomas: challenges and opportunities, Journal of Clinical Oncology, 3, 299-310.
13. Portlock, C. S. (1983). The role of treatment deferral in the management of patients with advanced indolent non-Hodgkin's lymphomas, Seminars in Hematology, 20, 25-34.
14. Portlock, C. S. and Rosenberg, S. A. (1979). No initial therapy for Stage III and IV non-Hodgkin's lymphomas of favourable histologic types, Annual Internal Medicine, 90, 10-13.
15. Young, R. C., Longo, D. L , Glatstein, E., Ihde, D. C., Jaffe, E. S. and De Vita, V. T. Jr (1988). The treatment of indolent lymphomas: Watchful waiting versus aggressive combined modality treatment. Seminars in Hematology, 25, 11-16.
16. Chen, M. G., Proznitz, L. R., Gonzales-Serva, A. and Fischer, D B. (1979). Results of radiotherapy in control of stage I and II non-Hodgkin's lymphoma, Cancer, 43, 1245-1254.
17. Gallacher, C. T., Gregory, W. M., Jones, A. E., Stanfeld, A. G., Richards, M. A., Dhaliwal, H. S., Malpas, J. S. and Lister, T. A. (1986). Follicular lymphoma: prognostic factors for response and survival. Journal of Clinical Oncology, 4, 1470-1480.
18. Gomez, G. A., Barcos, M., Krishnamsetry, R. M. et al. (1986). Treatment of early - stage I and II - nodular poorly differentiated lymphocytic lymphoma, American Journal of Clinical Oncology, 9, 40.
19. Longo, D. (1989). Cancer: Principles and Practice of Oncology Edited by V. T. De Vita., S. Hellman and S. A. Rosenberg. (Toronto; J. B. Lippincott Co Philadelphia).
20. Hoppe, R. T., Kushlan, P., Kaplan, H. S., Rosenburg, S A. and Brown, B. W. (1981). The treatment of advanced stage favourable histology non-Hodgkin's lymphoma: a preliminary report of a randomised trial comparing single agent chemotherapy, combination chemotherapy and whole body irradiation, Blood, 58, 592-589.
21. Paryani, S. B., Hoppe, R. T. and Cox, R. S. (1983). Analysis of non-Hodgkin's lymphomas with nodular and favourable histologies Stages I and II, Cancer, 52, 2300-2307.
22. Portlock, C. S., Fischer, D., Cadman, E., Lundburg, W. B., Levy, A., Bobrow, S., Bertino, J. R. and Farber, L. (1978). High-pulse chlorambucil in advanced, low-grade non-Hodgkin's lymphomas. Cancer Treatment Reports, 71, 1029-1031.
23. Sutcliffe, S. B., Gospodarowicz, M. K., Bush, R. A et al. (1985). Role of radiation therapy in localised non-Hodgkin's lymphoma, Radiotherapy and Oncology, 4, 211-223.
24. Cavallin-Stahl, E. and Moller, T. R. with the Swedish Lymphoma Group. (1986). Prednimustine, Cyclophosphamide-vincristine-Prednisolone in the treatment of non-Hodgkin's lymphoma with favourable histology, results of a national cancer care pogram in Sweden, Semininar in Oncology, 13, 19-22.
25. Longo, D. L., Young, R. C., Hubbard, S. M., Wesley, M , Fisher, I., Jaffe, E., Berard, C. and DeVita, V. T. (1984). Prolonged initial remission in patients with nodular mixed lymphomas, Annals in Internal Medicine, 100, 651-656.
26. Portlock, C. S., Rosenberg, S. A., Glatstein, E. and Kaplan, H. S. (1976). Treatment of advanced non-Hodgkin's lymphomas with favourable histologies: preliminary results of a prospective trial, Blood, 47, 747-756.
27. Rudders, R. A., Kaddis, M., De Lellis, R. A and Casey, H., Jr. (1979). Nodular non-Hodgkin's lymphoma. Factors influencing prognosis and indications for aggressive treatment. Cancer, 43, 1643-1651.
28. Ezdinli, E. Z., Anderson, J. R., Melvin, F., Glick, J. H , Davis, T. E. and O'Connell, M. J. (1985). Moderate versus aggressive chemotherapy of nodular lymphocytic poorly-differentiated lymphoma, Journal of Clinical Oncology, 3, 769-775
29. Anderson, T., Bender, R. A., Fischer, R. I., DeVita, V. T , Chabner, B. A, Berard, C. W., Norton, L and Young, R C. (1977). Combination chemotherapy in non-Hodgkin's lymphoma: results of long term follow-up, Cancer Treatment Reports, 61, 1057-1066.
30. Bittran, J. C , Golombick, H. M , Ultmann, J. E., Sweet, K. L., Lester, E. P., Stein, R. S., Miller, J. B., Morgan, E. M., Kinnealey, A. E., Vardiman, J. E., Kinzie, J. and Roth, N. O. (1978). Non-Hodgkin's lymphoma, poorly differentiated and mixed cell types: results of sequential staging procedures. response to therapy and survey of 100 patients, Cancer, 42, 88-95.
31. Glick, J. H., Barnes, J. M., Ezdinli, E. Z., Berard, C. W., Ordow, E L and Bennett, J M. (1981). A randomised trial failing to confirm prolonged disease free survival with COPP chemotherapy, Blood, 58, 920-925.
32. Oken, M. M., Costello, W. G., Johnson, G. J., Lenhard, R. E., Ezdinli, E. Z., Orlow, E., Barnes, J. M., Berand, C. W. and Glick, J. H (1983). The influence of histologic subype on toxicity and response to chemotherapy in non-Hodgkin's lymphoma, Cancer, 51, 1581-1586.
33. Lepage, E., Sebban, D., Gisselbrecht, C. et al. (1990). Treatment of low-grade non-Hodgkin's lymphomas assessment of Doxorubicin in a controlled trial, Hematologic Oncology, 8, 31-38.
34. Meller, G. E., Nathwani, B. M., Burk, J. S. et al (1985). Morpologic subclassification of follicufar lymphoma: Variability of diagnosis among hematopathologists, a collaborative study between the repository centre and pathology panel for clinical lymphoma studies, Journal of Clinical Oncology, 3, 25-38.
35. Gospodarowicz, M G., Bush, R. S., Brown, T. C. and Chua, T. (1984). Prognostic factors in nodular lymphomas: a multivariate analysis based on the Princess Margaret Hospital experience, International Journal of Radiology Oncology and Biology Physics, 10, 489-497.
36. Qazi, R., Aisenberg, A. C. and Long, C. J. (1976). The natural history of nodular lymphoma, Cancer, 37, 1923-1927.
37. Cabanillas, F., Smith, T., Bodey, C. P., Gutterman, J. U. and Freireich, E. J. (1979). Nodular malignant lymphomas: factors affecting complete response and survival, Cancer, 44, 1983-1989.
38. Bastion, Y., Berger, F., Bryon, P. P., Felman, P., Ffrench, M. and Coiffier, B. (1991). Follicular lymphomas: assessment of prognostic factors in 127 patients followed for 10 years, Annals in Oncology, 2(Supp 2), 123-129.
39. Romaguera, J E., McLauglin, P., North, L., Dixon, D., Silvermintz, K B., Garnsey, L. A. Velasquez, W. S., Hagemeister, F. B. and Cabanillas, F. (1991). Multivariate analysis of prognostic factors in stage IV follicular low-grade lymphomas, a risk model. Journal of Clinical Oncology, 9, 9762-9769.
40. McLauglin, P., Fuller, L M , Velasquez, W. S., Sullivan-Halley, J. A , Butler, J. J. and Cabanillas, F. (1986) Stage I-II follicular lymphoma, treatment results of 76 patients, Cancer, 58, 1596-1602.
41. Warnke, R. A., Kim, H., Fuks, Z., Dorfman, R. F. (1977) The co-existence of nodular and diffuse patterns in nodular non-Hodgkin's lymphomas: Significance and clinicopathologic correlation, Cancer, 40, 1229-1233.
42. Bennet, J. M , Cain, K C , Glick, J. H. et al. (1986). The significance of bone marrow involvement in non-Hodgkin's lymphoma: The Eastern co-operative Oncology Group experience, Journal of Clinical Oncology, 4, 1462-1469
43. Gallagher, C. J., Gregory, W. M., Jones, A E., Stanfeld, A. G., Richards, M. A., Dhaliwal, H. S., Malpas, J. S. and Lister, T. A (1986). Follicular lymphoma: prognostic factors for response and survival, Journal of Clinical Oncology, 4, 1470-1480
44. Anderson, T., De Vita, V. T., Simon, R. M., Berard, C. W., Canellos, G P., Garvin, A. J. and Young, R. C. (1982). Malignant lymphoma II. Prognostic factors and response to treatment of 473 patients at the National Cancer Institute, Cancer, 50, 2708-2721.
45. Steward, W. P., Crowther, D., McWilliam, L. J., Jones, J. M., Deakin, D. P., Todd, I. D. H., Blackledge, G., Wagstaff, J., Scarffe, J. H. and Harris, M. (1988). Maintainance chlorambucil after CVP in the management of advanced stage, low-grade histologic type non-Hodgkin's lymphoma, Cancer, 61, 441-447.
46. Diggs, C. H., Wiernik, P. M., Ostrow, S. S. et al. (1981). Nodular lymphoma. Prolongation of survival by complete remission, Cancer Clinical Trials, 4, 107-114.